ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,863Medicare Part D Prescriptions Filled, Including Refills

Rank: 189 out of 946

$585K Total Retail Price of All Prescriptions

Rank: 147 out of 946

565 Patients Receiving at Least One Drug in Part D
83% Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Arizona
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

9% of this provider’s 565 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

7% of this provider’s 565 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 420 357 107 1 1
LISINOPRIL 390 310 113 2 2
AMLODIPINE BESYLATE 364 320 102 3 4
SIMVASTATIN 321 254 90 4 3
OMEPRAZOLE 195 154 65 5 5
TRAMADOL HCL 185 135 42 6 25
ALPRAZOLAM 182 131 44 B 7 29
POTASSIUM CHLORIDE 177 135 52 8 17
HYDROCHLOROTHIAZIDE 157 119 49 9 14
FUROSEMIDE 150 127 42 10 9
WARFARIN SODIUM 150 134 27 10 11
HYDROCODONE-ACETAMINOPHEN 145 95 33 S3 12 10
METOPROLOL TARTRATE 143 114 43 13 8
GABAPENTIN 140 103 37 14 12
ATORVASTATIN CALCIUM 136 110 42 15 7
OXYCODONE-ACETAMINOPHEN 132 62 23 S2 16 39
ATENOLOL 126 99 36 17 15
METFORMIN HCL 119 102 33 18 6
PANTOPRAZOLE SODIUM 110 80 25 19 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 107 96 38 20 47
PROAIR HFA 99 50 40 21 38
ZOLPIDEM TARTRATE 96 96 27 22 20
OXYCODONE HCL 92 54 18 S2 23 41
SPIRIVA 86 68 32 24 75
CLOPIDOGREL 83 63 19 25 19
FLUTICASONE PROPIONATE 83 46 29 25 23
TEMAZEPAM 81 51 15 B 27 57
PRAVASTATIN SODIUM 77 72* 25 28 16
TRIAMTERENE-HCTZ 77 72* 18 28 42
METOPROLOL SUCCINATE 76 71* 22 30 18
CRESTOR 74 74 18 31 30
CARVEDILOL 73 62 22 32 37
GLYBURIDE-METFORMIN HCL 72 67* 19 R 33 232
LORAZEPAM 71 49 12 B 34 31
CLONAZEPAM 68 26 14 B 35 58
TRAZODONE HCL 67 54 23 36 34
MONTELUKAST SODIUM 64 40 19 37 52
FENTANYL 64 <11 <11 S2 37 134
RANITIDINE HCL 61 31 16 39 32
KLOR-CON M10 59 54* 22 40 156
MORPHINE SULFATE ER 58 <11 <11 S2 41 56
CARISOPRODOL 57 <11 11 R 42 93
PAROXETINE HCL 57 52* 12 42 55
SERTRALINE HCL 57 46 15 42 26
TAMSULOSIN HCL 53 48* 17 45 27
DIAZEPAM 53 <11 <11 B 45 101
GLYBURIDE 52 47* 15 R 47 72
ALENDRONATE SODIUM 50 45* 11 48 28
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 30, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.